197 related articles for article (PubMed ID: 15361398)
1. Low dose warfarin treatment for calcinosis in patients with systemic sclerosis.
Cukierman T; Elinav E; Korem M; Chajek-Shaul T
Ann Rheum Dis; 2004 Oct; 63(10):1341-3. PubMed ID: 15361398
[TBL] [Abstract][Full Text] [Related]
2. The effects of warfarin on calcinosis in a patient with systemic sclerosis.
Yoshida S; Torikai K
J Rheumatol; 1993 Jul; 20(7):1233-5. PubMed ID: 8371227
[TBL] [Abstract][Full Text] [Related]
3. Treatment of calcinosis universalis with low-dose warfarin.
Berger RG; Featherstone GL; Raasch RH; McCartney WH; Hadler NM
Am J Med; 1987 Jul; 83(1):72-6. PubMed ID: 3605184
[TBL] [Abstract][Full Text] [Related]
4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Skin Calcifications with Intra-lesional Injection of Sodium Thiosulphate: A Case Series.
Baumgartner-Nielsen J; Olesen AB
Acta Derm Venereol; 2016 Feb; 96(2):257-8. PubMed ID: 26258586
[No Abstract] [Full Text] [Related]
6. Calcinosis in rheumatic diseases.
Boulman N; Slobodin G; Rozenbaum M; Rosner I
Semin Arthritis Rheum; 2005 Jun; 34(6):805-12. PubMed ID: 15942915
[TBL] [Abstract][Full Text] [Related]
7. [Calcinosis universalis associated with dermatomyositis. A report on five cases (author's transl)].
Godeau P; Herson S; Ghozlan R; Bletry O; Richard C; Herreman G
Sem Hop; 1980 Dec 8-15; 56(45-46):1871-5. PubMed ID: 6256893
[TBL] [Abstract][Full Text] [Related]
8. Calcinosis universalis in a case of progressive systemic sclerosis.
Murthy VP; Rao GR; Rao PS
J Assoc Physicians India; 1998 May; 46(5):482-4. PubMed ID: 11273298
[No Abstract] [Full Text] [Related]
9. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.
Davies CA; Jeziorska M; Freemont AJ; Herrick AL
Rheumatology (Oxford); 2006 Nov; 45(11):1349-55. PubMed ID: 17050587
[TBL] [Abstract][Full Text] [Related]
10. Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room.
Habib G; Nashashibi M; Khateeb A; Goichman S; Kogan A
Eur J Intern Med; 2008 Mar; 19(2):129-34. PubMed ID: 18249309
[TBL] [Abstract][Full Text] [Related]
11. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis with an unusual rapid development of huge calcinosis (tumoral calcinosis).
Aozasa N; Asano Y; Ashida R; Tamaki Z; Yamamoto M; Tomita M; Kawashima T; Sugaya M; Tamaki K; Sato S
J Dermatol; 2011 Aug; 38(8):836-8. PubMed ID: 21366673
[No Abstract] [Full Text] [Related]
13. Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature.
Daoussis D; Antonopoulos I; Liossis SN; Yiannopoulos G; Andonopoulos AP
Semin Arthritis Rheum; 2012 Jun; 41(6):822-9. PubMed ID: 22221908
[TBL] [Abstract][Full Text] [Related]
14. [Warfarin in the treatment of antiphospholipid syndrome].
Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
[TBL] [Abstract][Full Text] [Related]
15. [Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis].
Vorob'eva NM; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Kirienko AI; Panchenko EP
Ter Arkh; 2008; 80(7):50-4. PubMed ID: 18763596
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
Riley P; McCann LJ; Maillard SM; Woo P; Murray KJ; Pilkington CA
Rheumatology (Oxford); 2008 Jun; 47(6):877-80. PubMed ID: 18403404
[TBL] [Abstract][Full Text] [Related]
17. Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis.
Davies CA; Herrick AL; Cordingley L; Freemont AJ; Jeziorska M
Rheumatology (Oxford); 2009 Aug; 48(8):876-82. PubMed ID: 19542215
[TBL] [Abstract][Full Text] [Related]
18. Topical sodium metabisulfite for the treatment of calcinosis cutis: a promising new therapy.
Del Barrio-Díaz P; Moll-Manzur C; Álvarez-Veliz S; Vera-Kellet C
Br J Dermatol; 2016 Sep; 175(3):608-11. PubMed ID: 26799451
[TBL] [Abstract][Full Text] [Related]
19. Digital calcification in systemic sclerosis: effective treatment with good tissue preservation using the carbon dioxide laser.
Bottomley WW; Goodfield MJ; Sheehan-Dare RA
Br J Dermatol; 1996 Aug; 135(2):302-4. PubMed ID: 8881679
[TBL] [Abstract][Full Text] [Related]
20. Calcinosis cutis: a rare feature of adult dermatomyositis.
Lobo IM; Machado S; Teixeira M; Selores M
Dermatol Online J; 2008 Jan; 14(1):10. PubMed ID: 18319027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
